Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;29(4):201-202.
doi: 10.1177/09727531221125589. Epub 2022 Sep 15.

Switching to Tenecteplase from Alteplase for Ischemic Stroke: Is it the Time for Universal Adoption?

Sanjeev Kharel  1 , Riwaj Bhagat  2
Affiliations

Switching to Tenecteplase from Alteplase for Ischemic Stroke: Is it the Time for Universal Adoption?

Sanjeev Kharel et al. Ann Neurosci. 2022 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.

Similar articles

See all similar articles

References

    1. Coutts SB, Yu AYX.. Tenecteplase for acute stroke: the thrombolysis puzzle. The Lancet Neurology 2022; 21(6): 496–497. - PubMed
    1. Katsanos AH, Psychogios K, Turc G, Sacco S, de Sousa DA, de Marchis GM, et al.. Off-label use of tenecteplase for the treatment of acute ischemic stroke. JAMA Network Open 2022; 5(3): e224506. - PMC - PubMed
    1. Burgos AM, Saver JL.. Evidence that tenecteplase is noninferior to alteplase for acute ischemic stroke. Stroke 2019; 50(8): 2156–2162. - PubMed
    1. Menon BK, Buck BH, Singh N, Deschaintre Y, Almekhlafi MA, Coutts SB, et al.. Intravenous tenecteplase compared with alteplase for acute ischemic stroke in Canada (AcT): A pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial. The Lancet 2022; 400(10347):161–169. - PubMed
    1. Katsanos AH, Safouris A, Sarraj A, Magoufis G, Leker RR, Khatri P, et al.. Intravenous thrombolysis with tenecteplase in patients with large vessel occlusions. Stroke 2021; 52(1): 308–312. - PubMed